ribonucleotide reductase inhibitor
(RY-boh-NOO-klee-oh-tide ree-DUK-tays in-HIH-bih-ter)
A family of anticancer drugs that interfere with the growth of tumor cells by blocking the formation of deoxyribonucleotides (building blocks of DNA).
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.